Last reviewed · How we verify
An Open-label, Multiple-dosing, Two-arm, One-sequence, Crossover Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Amlodipine 10mg and Candesartan 32mg in Healthy Male Volunteers
Clinical trial to evaluate the pharmacokinetic interactions and safety between single dose of amlodipine 10mg and candesartan 32mg and the combination dose amlodipine 10mg with candesartan 32mg in healthy male volunteers.
Details
| Lead sponsor | Shin Poong Pharmaceutical Co. Ltd. |
|---|---|
| Phase | Phase 1 |
| Status | COMPLETED |
| Enrolment | 34 |
| Start date | 2013-07 |
| Completion | 2013-08 |
Conditions
- Healthy
Interventions
- candesartan cilexetil 32mg, amlodipine 10mg
Primary outcomes
- AUC, Cmax — 7days, 10days
Countries
South Korea